Antonello Bonci
Founder, President and Chief Scientific Officer
GIA Healthcare

Dr. Antonello Bonci is the President and Founder of GIA Miami and one of the Founders and Scientific Director of Brain&Care. Before moving to GIA Miami, he served for nearly a decade at the National Institute of Health (NIH) as Scientific Director of the National Institute on Drug Abuse (NIDA) at the NIH. Between 1999 and 2010, he was Professor-in-Residence in the Department of Neurology at the University of California, San Francisco (UCSF).
Dr. Bonci is known worldwide for his pioneering studies on the long-term effects of stress and drug exposure on the brain. In 2013, a pioneering study published in Nature by his team, provided the scientific rationale for the use of non-invasive brain stimulation, such as repeated Transcranial Magnetic Stimulation (TMS), in patients with cocaine use disorders and other types of addictions. Based on this work, in 2021 the TMS company Mag Venture received CE approval for the treatment of addictions.

Dr. Bonci has received numerous international awards, such as the D. Efron Award at the American College of Neuropsychopharmacology, the Jacob P. Waletzky Memorial Award at the Society for Neuroscience, and the FENS and ENJ Research Award. His work has been featured worldwide in media venues such as NPR, NBC, CBS news and BBC.

He is an active member of the National Academy of Medicine, the American Academy of Physicians, the American Neurological Association, the Dana Alliance for Brain Initiatives, a fellow of the American College of Neuropsychopharmacology, and a Member of the Advisory Council at BBRF.



Benefits of Non-Invasive Brain Stimulation in the Era of COVID-19

Friday, September 06, 2024
8:30 AM - 10:00 AM